Loading...
Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening
BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status...
Na minha lista:
| Udgivet i: | BMC Pediatr |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247172/ https://ncbi.nlm.nih.gov/pubmed/34210267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-021-02751-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|